Impressively, TXL could inhibit the stroke‐enhanced expression of adhesion molecules (P‐selectin and ICAM‐1) and chemokines (CCL‐3, CCL‐4, CCL‐5, and CXCL1). This evidence concerns the gene CCL3 and stroke disorder.